【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 8
2 Introduction 9
2.1 Melanoma Overview 9
3 Products under Development 10
3.1 Melanoma – Pipeline Products by Stage of Development 10
3.2 Melanoma – Pipeline Products by Territory 11
3.3 Melanoma – Pipeline Products by Regulatory Path 12
3.4 Melanoma – Pipeline Products by Estimated Approval Date 13
3.5 Melanoma – Ongoing Clinical Trials 14
4 Melanoma – Pipeline Products under Development by Companies 15
4.1 Melanoma Companies – Pipeline Products by Stage of Development 15
4.2 Melanoma – Pipeline Products by Stage of Development 17
5 Melanoma Companies and Product Overview 19
5.1 Abbott Diagnostics Company Overview 19
5.1.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 19
5.2 Adaptive Biotechnologies Corporation Company Overview 23
5.2.1 Adaptive Biotechnologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 23
5.3 Advanced Cell Diagnostics, Inc. Company Overview 25
5.3.1 Advanced Cell Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
5.4 Agilent Technologies, Inc. Company Overview 26
5.4.1 Agilent Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
5.5 BioMarker Strategies, LLC Company Overview 28
5.5.1 BioMarker Strategies, LLC Pipeline Products & Ongoing Clinical Trials Overview 28
5.6 Biosceptre (Aust) Pty Ltd Company Overview 30
5.6.1 Biosceptre (Aust) Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 30
5.7 Boston University Company Overview 31
5.7.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 31
5.8 Ceres Nanosciences, Inc. Company Overview 32
5.8.1 Ceres Nanosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
5.9 Dana-Farber Cancer Institute, Inc. Company Overview 33
5.9.1 Dana-Farber Cancer Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
5.10 Digna Biotech, S.L. Company Overview 34
5.10.1 Digna Biotech, S.L. Pipeline Products & Ongoing Clinical Trials Overview 34
5.11 Exosomics Siena SpA Company Overview 35
5.11.1 Exosomics Siena SpA Pipeline Products & Ongoing Clinical Trials Overview 35
5.12 Genomic Health, Inc. Company Overview 36
5.12.1 Genomic Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
5.13 Hospital Universitario Cruces Company Overview 38
5.13.1 Hospital Universitario Cruces Pipeline Products & Ongoing Clinical Trials Overview 38
5.14 HTG Molecular Diagnostics, Inc. Company Overview 39
5.14.1 HTG Molecular Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 39
5.15 ImmunID Technologies Company Overview 41
5.15.1 ImmunID Technologies Pipeline Products & Ongoing Clinical Trials Overview 41
5.16 InterGenetics Incorporated Company Overview 45
5.16.1 InterGenetics Incorporated Pipeline Products & Ongoing Clinical Trials Overview 45
5.17 IV Diagnostics, Inc. Company Overview 46
5.17.1 IV Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
5.18 Louisville Bioscience, Inc. Company Overview 47
5.18.1 Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
5.19 MDNA Life Sciences, Inc. Company Overview 48
5.19.1 MDNA Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
5.20 Melanovus Oncology, Inc. Company Overview 49
5.20.1 Melanovus Oncology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
5.21 MolecularMD, Corp. Company Overview 50
5.21.1 MolecularMD, Corp. Pipeline Products & Ongoing Clinical Trials Overview 50
5.22 Myriad Genetics, Inc. Company Overview 51
5.22.1 Myriad Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
5.23 Orion Genomics LLC Company Overview 53
5.23.1 Orion Genomics LLC Pipeline Products & Ongoing Clinical Trials Overview 53
5.24 Oryzon Genomics S.A. Company Overview 54
5.24.1 Oryzon Genomics S.A. Pipeline Products & Ongoing Clinical Trials Overview 54
5.25 Pacific Edge Limited Company Overview 56
5.25.1 Pacific Edge Limited Pipeline Products & Ongoing Clinical Trials Overview 56
5.26 Qiagen N.V. Company Overview 58
5.26.1 Qiagen N.V. Pipeline Products & Ongoing Clinical Trials Overview 58
5.27 Roche Diagnostics International Ltd. Company Overview 60
5.27.1 Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview 60
5.28 Rosetta Genomics, Ltd. Company Overview 64
5.28.1 Rosetta Genomics, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 64
5.29 Sividon Diagnostics GmbH Company Overview 66
5.29.1 Sividon Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 66
5.30 SomaLogic, Inc. Company Overview 67
5.30.1 SomaLogic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
5.31 The Johns Hopkins University Company Overview 68
5.31.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 68
5.32 University of California, San Francisco Company Overview 70
5.32.1 University of California, San Francisco Pipeline Products & Ongoing Clinical Trials Overview 70
5.33 University of Colorado Company Overview 72
5.33.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 72
5.34 University of Louisville Company Overview 73
5.34.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 73
5.35 Zymera, Inc Company Overview 74
5.35.1 Zymera, Inc Pipeline Products & Ongoing Clinical Trials Overview 74
6 Melanoma- Recent Developments 75
7 Appendix 83
7.1 Methodology 83
7.2 About GlobalData 85
7.3 Contact Us 86
7.4 Disclaimer 86
【レポート販売概要】
■ タイトル:世界における黒色腫検査製品のパイプライン動向2015■ 英文:Melanoma - Pipeline Review, 2015
■ 発行日:2015年10月1日
■ 調査会社:GlobalData
■ 商品コード:GDME0078EPD
■ 調査対象地域:グローバル
- 1,1,2,2-Tetrafluoroethaneの世界市場1,1,2,2-TETRAFLUOROETHANE (CAS 359-35-3) Market Research Report 2012 presents comprehensive data on 1,1,2,2-tetrafluoroethane markets globally and regionally (Europe, Asia, North America etc.) The report includes 1,1,2,2-tetrafluoroethane description, covers its application areas and related patterns. It overviews 1,1,2,2-tetrafluoroethane market, names 1,1,2,2-tetrafluoroethane producers and indi …
- 世界の小売自動化市場:POS製品別、サプライチェーン別、地域別分析The global retail industry is developing at a high growth rate due to many reasons like increasing retailers’ investment in the retail sector, high demand from the customer, increasing population, and so on. Retailers require advanced and developed systems to meet current market needs; such as reducing the operational costs for retail stores, obtaining accurate results during transactions and, fas …
- グローバル軍事航空市場(2014-2024):SWOT分析Synopsis This report provides readers with an exhaustive analysis of industry characteristics, determining the strengths, weaknesses, opportunities and threats faced by the Military Aviation market. Summary This SWOT analysis of Military Aviation market is a crucial resource for industry executives and anyone looking to gain a better understanding of the market. SDI's "The Global Military Aviation …
- Gasco Energy Inc.:石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Gasco Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Gasco Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key …
- 熱成形プラスチックの世界市場2019-2023About this market The growing demand for thermoformed plastics from the food packaging industry is one of the critical reasons that will drive the thermoformed plastics market. Thermoformed plastics are not only used to manufacture trays, cups, clamshells, and containers but also tri-fold packs and blister packs. These plastics are manufactured using polystyrene, PET, and polypropylene. The global …
- Procure-To-Pay(購買支払管理)アウトソーシングの世界市場2016-2020About P2P Outsourcing Procurement is a relatively new area of outsourcing. Procurement organizations face constraints in delivery due to the lack of resources. Companies often have to deal with declining budgets because of volatile economic conditions. CPOs are often forced to accomplish more with fewer resources. Budgetary restrictions are thus encouraging CPOs to seek low-cost delivery solutions …
- 無菌試験の世界市場予測(~2021):装置、サービス、キット、試薬The sterility testing market is expected to reach USD 941.0 Million by 2021 from USD 528.0 Million in 2016, at a CAGR of 12.3%. The global market is segmented on the basis of product, test, and application. Sterility testing is an important and mandatory step in the manufacturing process to remove or inactivate potential bacterial contaminants. Growth in the pharmaceutical and biotechnology indust …
- Mantle Cell Lymphoma:グローバル臨床試験レビューH2, 2013Mantle Cell Lymphoma Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Mantle Cell Lymphoma Global Clinical Trials Review, H2, 2013" provides data on the Mantle Cell Lymphoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Mantle Cell Lymphoma. It includes an overview of the trial numbers and their r …
- 世界の医療産業におけるMEMS技術動向(2012-2016)TechNavio's analysts forecast the Global MEM Technology market in the Healthcare industry to grow at a CAGR of 34.8 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growing need for high operating speed medical devices. The Global MEM Technology market in the Healthcare industry has also been witnessing the miniaturization of medical electronic de …
- Azilect (パーキンソン病):医薬品市場予測及び分析(~2022)Azilect (Parkinson’s Disease) - Forecast and Market Analysis to 2022 Summary Parkinson’s disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural instability. As the second most common neurodegenerative disorder, Parkinson’s disease may affect individuals of any age but prevalence is increased with age and it is most common in the elderly. D …
- ピック病(Pick’s Disease):グローバル臨床試験動向(2014年上半期)Pick's Disease Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Pick's Disease Global Clinical Trials Review, H1, 2014" provides data on the Pick’s Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pick’s Disease It includes an overview of the trial numbers and their recruitment status as per …
- バイオ医療用金属材料の世界市場:ステンレス鋼、チタン合金、コバルト合金、マグネシウムAbout Biomedical Metal Biomedical metals are being used for a number of applications in the Medical sector. The metals commonly used are stainless steel, titanium-based alloys, cobalt-based alloys, nitinol, magnesium and related metals. Stainless steel is the most widely used metal because of its biocompatibility and cost-effectiveness. Biomedical metal find a wide range of applications in implant …
- マイコトキシン試験の世界市場予測(~2022):種類別(アフラトキシン、オクラトキシンA、パチュリン、フザリウム毒素群)、技術別(高速液体クロマトグラフ(HPLC)ベース、液体クロマトグラフィー・タンデム質量分析法(LC-MS / MS)ベース、免疫測定法ベース)、テスト食品別(飼料・食品)、地域別“Mycotoxin testing market projected to grow at a CAGR of 6.0%”The mycotoxin testing market is projected to reach USD 1.56 billion by 2022, at a CAGR of 6.0% from 2016 to 2022. The market is driven by factors such as humid atmospheric conditions leading to increase in mycotoxins production in food & feed products, implementation of stringent food safety regulations, international trade mandates, gr …
- 世界の露光装置市場:Global Lithography Systems Market 2014-2018TechNavio's analysts forecast the Global Lithography Systems market to grow at a CAGR of 3.06 percent over the period 2013-2018. One of the key factors contributing to this market growth is the rising demand for smartphones and tablets. The Global Lithography Systems market has also been witnessing the short replacement cycle of portable electronic devices. However, the cyclical nature of the Semi …
- ソフトカバーリングフローリングの世界市場分析:製品別(カーペット、広幅じゅうたん)、用途別(住居用、商業用)、セグメント予測、-2020The global soft covering flooring market size is expected to reach USD 152.45 billion by 2020, growing at a CAGR of approximately 5% from 2014 to 2020. Rising urban population and changing lifestyles is expected to drive growth over the forecast period. Soft coverings comprise carpet tiles, broadloom, and rugs equipped with dust-binding characteristics. They offer comfort along with noise reductio …